Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 2003, p. 715-717, Vol. 10, No. 4
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.4.715-717.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Thania Cabrera,1 James H. Marshall,1 Celso Bianco,3 Renu B. Lal,1 and Elliot P. Cowan2
Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852,2 America's Blood Centers, Washington, D.C. 200053
Received 13 January 2003/ Returned for modification 11 March 2003/ Accepted 13 March 2003
A potential public health concern is the reported detection of the human T-lymphotropic virus (HTLV) tax gene in the lymphocytes of up to 11% of a low-risk group of New York City blood donors (NYBD). This study aimed to independently confirm the prevalence of HTLV tax sequences in 293 NYBD. All NYBD tested negative for antibodies to HTLV types 1 and 2 and HTLV Tax. HTLV tax sequences were not detected in the NYBD lymphocytes. These data demonstrate the lack of HTLV-1 tax in this group of NYBD at low risk for HTLV infection.
Present address: Division of Extramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Rockville, MD 20892.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»